Page last updated: 2024-08-16

phenylephrine and Glucose Intolerance

phenylephrine has been researched along with Glucose Intolerance in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbas, A; Beech, DJ; Channon, KM; Cubbon, RM; Gage, M; Galloway, S; Grant, PJ; Imrie, H; Kahn, M; Kearney, MT; Rajwani, A; Smith, J; Sukumar, P; Viswambharan, H; Wheatcroft, SB; Xuan, S; Yuldeshava, N	1

Other Studies

1 other study(ies) available for phenylephrine and Glucose Intolerance

Article	Year
The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium. Diabetes, 2011, Volume: 60, Issue:8 Topics: Animals; Aorta; Biological Availability; Down-Regulation; Endothelial Cells; Glucose; Glucose Intolerance; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type III; Phenylephrine; Receptor, IGF Type 1; Receptor, Insulin; Signal Transduction; Umbilical Veins; Vasoconstriction	2011

Article

Year

The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium.

Diabetes, 2011, Volume: 60, Issue:8

Topics: Animals; Aorta; Biological Availability; Down-Regulation; Endothelial Cells; Glucose; Glucose Intolerance; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type III; Phenylephrine; Receptor, IGF Type 1; Receptor, Insulin; Signal Transduction; Umbilical Veins; Vasoconstriction

2011